As of Oct 08
| -0.06 / -4.72%|
The 2 analysts offering 12-month price forecasts for Amarantus Bioscience Holdings Inc have a median target of 31.67, with a high estimate of 45.34 and a low estimate of 18.00. The median estimate represents a +2,517.36% increase from the last price of 1.21.
The current consensus among 1 polled investment analysts is to Buy stock in Amarantus Bioscience Holdings Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.